- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Human Endometrial Cancer Organoid Growth Medium |
| Catalog No. | RESK-0657 |
| Description | Human Endometrial Cancer Organoid Growth Medium is a serum-free medium designed for the establishment and long-term culture of endometrial cancer organoids derived from human cells or tissues. In the presence of an extracellular matrix, the proprietary components and abundant cytokines in the medium promote the rapid growth of endometrial cancer cells and the formation of endometrial cancer organoids. Organoid formation is smooth and rapid while maintaining high endometrial cancer cell characteristics and viability, providing support for subsequent physiological function studies, disease research, and precision medicine based on endometrial cancer organoids. Key features: 1. Broad application: suitable for tumor disease modeling, drug efficacy evaluation, toxicity assessment, and more. 2. Efficient and stable culture performance while preserving tumor heterogeneity. |
| Intended Use | Establishment and long-term culture of human endometrial cancer organoids for tumor disease modeling, drug efficacy evaluation, toxicity assessment, disease research, and precision medicine. |
| Principle / Technology | Organoid culture technology. This serum-free complete medium contains proprietary components and a rich blend of cytokines that, in the presence of an extracellular matrix (basement membrane matrix), drive endometrial cancer cells to grow rapidly and self-organize into endometrial cancer organoids. |
| Sample Type | Human cells and tissues |
| Performance Range / Specifications | 1. Broad application: suitable for tumor disease modeling, drug efficacy evaluation, toxicity assessment, and more. 2. Efficient and stable culture performance while preserving tumor heterogeneity. |
| Reaction Conditions / Protocol | Culture endometrial cancer organoids using an organoid-specific basement membrane matrix together with this medium: 1. Embed isolated endometrial cancer cells or processed tumor tissue fragments in the basement membrane matrix and allow the matrix to solidify. 2. Overlay the matrix with this growth medium and maintain the culture. 3. Refresh the medium and passage the organoids as required for long-term expansion. |
| Components / Formulation | Serum-free complete medium containing proprietary components and abundant cytokines. Supplied as two components: Part I and Part II. Combine both parts before use to obtain the complete medium. |
| Storage Conditions | Part I: Store at 2-8 °C, protected from light. Part II: Store at -25 °C to -15 °C. |
| Shelf Life | 12 months |
| Package Specifications | 100 mL, 500 mL |
| Product Form | Liquid |
| Source / Origin | Human |
| Shipping Conditions | Part I: Shipped with ice packs. Part II: Shipped at room temperature. |
| Regulatory / Compliance | For research use only. |
| Compatibility | For organoid culture, use together with an organoid-specific basement membrane matrix (extracellular matrix). |
| Application Notes / Precautions | 1. Store Part I protected from light at 2-8 °C and Part II at -25 °C to -15 °C. 2. For research use only. |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagnoTech. All rights reserved.
